Sagers JE - Search Results

1

Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.

Sagers JE, Brown AS, Vasilijic S, Lewis RM, Sahin MI, Landegger LD, Perlis RH, Kohane IS, Welling DB, Patel CJ, Stankovic KM. Sagers JE, et al. Sci Rep. 2018 Apr 3;8(1):5437. doi: 10.1038/s41598-018-23609-7. Sci Rep. 2018. PMID: 29615643 Free PMC article.

2

Cochlear Implantation: Vast Unmet Need to Address Deafness Globally.

Şahin Mİ, Sagers JE, Stankovic KM. Şahin Mİ, et al. Among authors: sagers je. Otol Neurotol. 2017 Jul;38(6):786-787. doi: 10.1097/MAO.0000000000001416. Otol Neurotol. 2017. PMID: 28437361 Free PMC article. No abstract available.

3

A Unified Methodological Framework for Vestibular Schwannoma Research.

Landegger LD, Sagers JE, Dilwali S, Fujita T, Sahin MI, Stankovic KM. Landegger LD, et al. Among authors: sagers je. J Vis Exp. 2017 Jun 20;(124):55827. doi: 10.3791/55827. J Vis Exp. 2017. PMID: 28654042 Free PMC article.

4

Human Cochlear Histopathology Reflects Clinical Signatures of Primary Neural Degeneration.

Sagers JE, Landegger LD, Worthington S, Nadol JB, Stankovic KM. Sagers JE, et al. Sci Rep. 2017 Jul 7;7(1):4884. doi: 10.1038/s41598-017-04899-9. Sci Rep. 2017. PMID: 28687782 Free PMC article.

5

Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas.

Ren Y, Sagers JE, Landegger LD, Bhatia SN, Stankovic KM. Ren Y, et al. Among authors: sagers je. Sci Rep. 2017 Oct 10;7(1):12922. doi: 10.1038/s41598-017-13032-9. Sci Rep. 2017. PMID: 29018206 Free PMC article.

6

Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.

Sagers JE, Brown AS, Vasilijic S, Lewis RM, Sahin MI, Landegger LD, Perlis RH, Kohane IS, Welling DB, Patel CJ, Stankovic KM. Sagers JE, et al. Sci Rep. 2018 Nov 23;8(1):17449. doi: 10.1038/s41598-018-36016-9. Sci Rep. 2018. PMID: 30470790 Free PMC article.

7

Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.

Ahmed SG, Abdelnabi A, Maguire CA, Doha M, Sagers JE, Lewis RM, Muzikansky A, Giovannini M, Stemmer-Rachamimov A, Stankovic KM, Fulci G, Brenner GJ. Ahmed SG, et al. Among authors: sagers je. Neuro Oncol. 2019 Jul 11;21(7):854-866. doi: 10.1093/neuonc/noz065. Neuro Oncol. 2019. PMID: 30977509 Free PMC article.

8

NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss.

Sagers JE, Sahin MI, Moon I, Ahmed SG, Stemmer-Rachamimov A, Brenner GJ, Stankovic KM. Sagers JE, et al. Hear Res. 2019 Sep 15;381:107770. doi: 10.1016/j.heares.2019.07.007. Epub 2019 Jul 17. Hear Res. 2019. PMID: 31430634

9

Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.

Sagers JE, Beauchamp RL, Zhang Y, Vasilijic S, Wu L, DeSouza P, Seist R, Zhou W, Xu L, Ramesh V, Stankovic KM. Sagers JE, et al. Sci Rep. 2020 Mar 6;10(1):4211. doi: 10.1038/s41598-020-60156-6. Sci Rep. 2020. PMID: 32144278 Free PMC article.

10

MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas.

Ren Y, Hyakusoku H, Sagers JE, Landegger LD, Welling DB, Stankovic KM. Ren Y, et al. Among authors: sagers je. Front Cell Neurosci. 2020 Jul 28;14:191. doi: 10.3389/fncel.2020.00191. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32848608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters